Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA:603456)
China · Delayed Price · Currency is CNY 15.73
+0.99 (6.72%)
Aug 4, 2026, 3:00 PM CST
SHA:603456 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 5,213 | 5,509 | 5,161 | 5,523 | 5,445 | 4,063 |
Revenue Growth | -1.03% | 6.74% | -6.57% | 1.44% | 34.01% | 53.49% |
Gross Profit Gross Profit Growth | 1,778 | 1,863 | 1,590 | 1,999 | 1,822 | 1,317 |
Operating Income Operating Income Growth | 959.45 | 1,072 | 715.31 | 1,103 | 1,026 | 725.97 |
Net Income Net Income Growth | 591.64 | 730.07 | 606.1 | 1,033 | 921.17 | 633.9 |
Earnings Per Share EPS Growth | 0.67 | 0.82 | 0.68 | 1.16 | 1.11 | 0.76 |
EPS Growth | -9.54% | 20.59% | -41.38% | 4.50% | 46.05% | 61.70% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Specialty APIs (Active Pharmaceutical Ingredients) and Intermediates Specialty APIs (Active Pharmaceutical Ingredients) and Intermediates Growth | 1,159 |
Patented APIs and Intermediates Patented APIs and Intermediates Growth | 4,176 |
Others Others Growth | 80.94 |
Total Total Growth | 5,416 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,579 | 1,543 | 2,749 | 3,206 | 1,095 | 1,147 |
Total Debt Total Debt Growth | 5.59 | 63.62 | 412 | 415.49 | 351.44 | 704.58 |
Net Cash (Debt) Net Cash Growth | 1,574 | 1,479 | 2,337 | 2,791 | 743.98 | 442.29 |
Net Cash Growth | -34.30% | -36.69% | -16.27% | 275.13% | 68.21% | - |
Net Cash Per Share Net Cash Per Share Growth | 1.78 | 1.66 | 2.62 | 3.13 | 0.90 | 0.53 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,533 | 1,824 | 991.66 | 1,360 | 1,226 | 677.52 |
Capital Expenditures CapEx Growth | -603.99 | -660.09 | -888.96 | -929.44 | -713.79 | -579.88 |
Free Cash Flow Free Cash Flow Growth | 928.55 | 1,164 | 102.69 | 430.88 | 511.99 | 97.64 |
Free Cash Flow Growth | 13.10% | 1033.66% | -76.17% | -15.84% | 424.38% | 15.32% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 34.12% | 33.81% | 30.80% | 36.19% | 33.47% | 32.41% |
Operating Margin | 18.40% | 19.45% | 13.86% | 19.96% | 18.84% | 17.87% |
Pretax Margin | 14.48% | 16.69% | 14.16% | 21.38% | 20.27% | 18.33% |
Profit Margin | 11.35% | 13.25% | 11.74% | 18.71% | 16.92% | 15.60% |
FCF Margin | 17.81% | 21.13% | 1.99% | 7.80% | 9.40% | 2.40% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.300 | 0.300 | 0.300 | 0.500 | 0.400 | 0.250 |
Dividend Per Share Growth | -80.00% | 0% | -40.00% | 25.00% | 60.00% | 25.00% |
Dividend Yield | 2.04% | 1.69% | 2.28% | 2.23% | 1.03% | 0.49% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 23.53 | 21.62 | 20.21 | 21.08 | 38.43 | 73.90 |
Forward PE | 16.22 | 14.44 | 10.72 | 15.86 | 32.74 | 63.29 |
P/FCF Ratio | 14.94 | 13.56 | 119.26 | 50.54 | 69.14 | 479.75 |
PS Ratio | 2.66 | 2.87 | 2.37 | 3.94 | 6.50 | 11.53 |